| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $96.8M | +6.5% |
| SG&A Expense | $34.9M | +24.3% |
| Operating Income | -$131.7M | -10.7% |
| Income Tax | $0 | — |
| Net Income | -$117.5M | -3.2% |
| EPS (Basic) | -$2.40 | +8.0% |
| EPS (Diluted) | -$2.40 | +8.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.0M | -17.2% |
| Short-term Investments | $217.1M | -31.0% |
| Current Assets | $253.1M | -29.8% |
| Total Assets | $378.9M | -19.9% |
| Current Liabilities | $23.3M | +5.8% |
| Total Liabilities | $105.6M | +4.8% |
| Stockholders' Equity | $273.3M | -26.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.2M | -51.2% |
| Capital Expenditures | $28.1M | -40.3% |
| Investing Cash Flow | $79.0M | +142.8% |
| Financing Cash Flow | $691K | -99.7% |
| Free Cash Flow | -$114.3M | -9.8% |